Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Hydroxy Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101535467B discloses a novel biocatalytic route for chiral hydroxy acids using Fusarium proliferatum ECU2002, offering high optical purity and scalable manufacturing solutions.
Patent CN111269132B reveals a biomimetic pyridoxal catalytic route for high-purity chiral amino acids, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN113355367B reveals high-efficiency LlKAR enzyme for deracemization. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.